OXYGEN, USP
Peak0xygen
NDAINHALATIONGAS
Approved
Jul 2013
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 1w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
OXYGEN, USP is a medical gas administered via inhalation for respiratory support in patients requiring supplemental oxygen therapy. It is an essential therapeutic agent for hypoxemia and respiratory distress across acute and chronic care settings. Oxygen functions physiologically to restore arterial oxygen saturation and tissue oxygenation.
Peak
Peak lifecycle status indicates stable market maturity with modest competitive pressure (30), suggesting stable team sizing and incremental optimization focus rather than growth expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
OXYGEN, USP represents a stable, mature product with career opportunities concentrated in regulatory compliance, supply chain optimization, and commercial efficiency rather than growth-oriented innovation. Professionals joining this product manage commodity healthcare operations in a standardized, low-discretion market.
Regulatory Affairs SpecialistSupply Chain Manager
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.